MIR4677

Across TCGA pan-cancer cohorts, MIR4677 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated MIR4677 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher MIR4677 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4677 expression acts as an unfavorable survival marker, although some lineages such as CESC and CHOL show a favorable association.

ACC, KIRC, and UVM are the cancer types where MIR4677 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.605	0.873	<.001	94	view →
KIRC	DFS	Quartile	All	0.727	0.883	<.001	86	view →
UVM	OS	Tertile	III,IV	0.235	0.696	<.001	63	view →
MESO	OS	Median	II,III,IV	0.275	0.517	<.001	39	view →
READ	DFS	Tertile	All	0.425	0.742	.010	20	view →
UCEC	DFS	Tertile	All	0.612	0.655	.024	18	view →
PRAD	DFS	Median	All	0.844	0.919	.006	16	view →
THCA	OS	Median	II,III,IV	0.914	0.982	.009	15	view →
KICH	OS	Tertile	All	0.601	0.955	.014	14	view →
CESC	OS	Median	IV	0.753	0.372	.032	12	view →
LIHC	DFS	Quartile	II,III,IV	0.156	0.373	.009	11	view →
LUSC	DFS	Median	III,IV	0.429	0.822	.024	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

MIR4677–ACC (OS)

Open the ACC breakdown →